About
About Wanbangde Pharmaceutical Holding Group Co., Ltd
Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine, chemical raw materials, and chemical preparations in China and internationally. The company operates through two segments, the Pharmaceutical Manufacturing Business and the Medical Device Business. It offers drugs products used to treat cardiovascular and cerebrovascular diseases; and nervous, respiratory, mental, and digestive system diseases. The company also develops and sells human orthopedic implant devices, including orthopedic implant devices comprised of thoracolumbar fusion, cervical fusion, spinal internal fixation systems, independent fusion devices, unicompartmental knee joints, etc.; medical equipment; disposable sterile medical polymer consumables; and hospital engineering services. The company was formerly known as Wanbangde New Building Materials Co., Ltd. and changed its name to Wanbangde Pharmaceutical Holding Group Co., Ltd. in April 2020. Wanbangde Pharmaceutical Holding Group Co., Ltd. was founded in 1985 and is headquartered in Taizhou, China.
Visit company website
5 years, 5 months ago
Wanbangde Pharmaceutical Holding Group Co., Ltd is currently in a long term downtrend where the price is trading 6.9% below its 200 day moving average.
From a valuation standpoint, the stock is 95.0% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 0.2.
Wanbangde Pharmaceutical Holding Group Co., Ltd's total revenue rose by 10.4% to $5B since the same quarter in the previous year.
Its net income has dropped by 99.1% to $207K since the same quarter in the previous year.
Finally, its free cash flow grew by 66.5% to $-172M since the same quarter in the previous year.
Based on the above factors, Wanbangde Pharmaceutical Holding Group Co., Ltd gets an overall score of 3/5.